A randomized phase 2 study of abemaciclib versus docetaxel in patients with stage IV squamous cell lung cancer (SqCLC) previously treated with platinum-based chemotherapy.

被引：1
|
作者：
Scagliotti, Giorgio V.
Govindan, Ramaswamy
Hurt, Karla
Chiang, Alan
机构：
[1] Univ Turin, Turin, Italy
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Eli Lilly, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.TPS9101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS9101
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Phase 2 Study of Ramucirumab plus Weekly Docetaxel in Stage IV NSCLC Following Progression after Platinum-Based Chemotherapy
    Sebastian, Martin
    Ponce, Santiago
    Nikolinakos, Petros
    Varea, Rocio
    Chao, Bo
    Zimmermann, Annamaria
    Alexandris, Ekaterine
    Lee, Pablo
    Cappuzzo, Frederico
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1079 - S1080
  • [32] Phase I dose-finding and pharmacokinetic study of IV vinflunine in combination with methotrexate in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) previously treated with platinum-based chemotherapy.
    Mailliez, Audrey
    Rolland, Frederic
    Tourani, Jean Marc
    Lafond, Cedrik
    Cupissol, Didier
    Isambert, Nicolas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial
    Dancey, J
    Shepherd, FA
    Gralla, RJ
    Kim, YS
    LUNG CANCER, 2004, 43 (02) : 183 - 194
  • [34] Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial
    K. Alexopoulos
    C. Kouroussis
    N. Androulakis
    E. Papadakis
    M. Vaslamatzis
    S. Kakolyris
    G. Samelis
    E. Patila
    A. Vossos
    E. Samantas
    V. Georgoulias
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 257 - 262
  • [35] Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial
    Alexopoulos, K
    Kouroussis, C
    Androulakis, N
    Papadakis, E
    Vaslamatzis, M
    Kakolyris, S
    Samelis, G
    Patila, E
    Vossos, A
    Samantas, E
    Georgoulias, V
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (03) : 257 - 262
  • [36] Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy.
    Yi, S. Y.
    Ahn, M.
    Park, J. Y.
    Lee, H. R.
    Lee, J.
    Park, Y. H.
    Ahn, J. S.
    Park, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Randomized phase II study comparing docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma who are refractory to fluoropyrimidine and platinum-based chemotherapy: OGSG1201.
    Kii, Takayuki
    Yamamoto, Sachiko
    Hara, Hiroki
    Kawabata, Ryohei
    Kawada, Junji
    Takeno, Atsushi
    Matsuyama, Jin
    Ueda, Shugo
    Kawakami, Hisato
    Okita, Yoshihiro
    Endo, Shunji
    Kimura, Yutaka
    Yanagihara, Kazuhiro
    Okuno, Tatsuya
    Shimokawa, Toshio
    Satoh, Taroh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy
    Tambo, Yuichi
    Hosomi, Yukio
    Sakai, Hiroshi
    Nogami, Naoyuki
    Atagi, Shinji
    Sasaki, Yasutsuna
    Kato, Terufumi
    Takahashi, Toshiaki
    Seto, Takashi
    Maemondo, Makoto
    Nokihara, Hiroshi
    Koyama, Ryo
    Nakagawa, Kazuhiko
    Kawaguchi, Tomoya
    Okamura, Yuta
    Nakamura, Osamu
    Nishio, Makoto
    Tamura, Tomohide
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 217 - 226
  • [39] A pilot study of ipilimumab and nivolumab in recurrent extensive-stage small cell lung cancer after platinum-based chemotherapy.
    Chiang, Anne C.
    Austin, Matthew
    Stewart, Tyler F.
    Arammash, Mohammad
    Bhatt, Sunil
    Gettinger, Scott N.
    Goldberg, Sarah B.
    Wilson, Frederick Hugh
    Newton, Benjamin Robert
    Cohenuram, Michael Keith
    Sabbath, Kert D.
    Talsania, Ashita D.
    Russo, Armand Vincent
    Herbst, Roy S.
    Schalper, Kurt A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung
    Isaka, Tetsuya
    Nakayama, Haruhiko
    Yokose, Tomoyuki
    Ito, Hiroyuki
    Katayama, Kayoko
    Yamada, Kouzo
    Masuda, Munetaka
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 23 (01) : 19 - 25
12345